Novartis AG (NVS)
130.77
-0.24
(-0.18%)
USD |
NYSE |
Dec 10, 12:47
Novartis EPS Diluted (Quarterly): 2.020 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Roche Holding AG | -- |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Avidity Biosciences, Inc. | -1.265 |
| Monte Rosa Therapeutics, Inc. | -0.3287 |
| Tourmaline Bio, Inc. | -0.8966 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.921B |
| Revenue (Quarterly) | 13.88B |
| Total Expenses (Quarterly) | 9.957B |
| Enterprise Value | 274.07B |
| Gross Profit Margin (Quarterly) | 74.58% |
| Profit Margin (Quarterly) | 28.26% |
| Earnings Yield | 5.61% |
| Operating Earnings Yield | 6.71% |
| Normalized Earnings Yield | 5.902 |